Kanazawa University, report in Nature Communications on how the targeted suppression of lysosome function may lead to brain ...

A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled “Imipridones ONC201/ONC206 + RT/TMZ ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Glioblastoma has remained one of the toughest ... The discovery not only offers a potential new treatment strategy but also identifies ZNF638 as a biomarker that could help personalize ...

The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a ...

Our findings demonstrate for the first time that IRT therapy combining ONC201 or ONC206 with RT and TMZ may be a safe and effective therapeutic ...

7, 2025 — A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new ... Breakthrough in Childhood Brain Cancer ...

A new study has uncovered key drivers of brain cancer growth that could make it possible to predict or even slow down the rate at which these tumors ...

GBM is a malignant brain cancer amongst the ... accelerate our path to Phase 2 clinical trials and help patients with new treatment options." ...

GBM is a malignant brain cancer amongst the ... accelerate our path to Phase 2 clinical trials and help patients with new treatment options." GlioGuard has been founded on sound biophysical ...